Announcements Trials
Browse Landscape

Phase

Phase 4 8Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 22Breast Neoplasms 21Polycystic Ovary Syndrome 12Carcinoma, Non-Small-Cell Lung 11Colorectal Neoplasms 10Lung Neoplasms 8Endometrial Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Glioblastoma 5Rectal Neoplasms 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Insulin Resistance 4Adenocarcinoma of Lung 4Adenocarcinoma 4Uterine Cervical Neoplasms 3Leukoplakia, Oral 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2Neoplasm Metastasis 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hyperandrogenism 2Esophageal Neoplasms 2Erythroplasia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Colonic Neoplasms 2

Interventions

salicylsalicylic acid 1maltodextrin 1Sodium Salicylate 1Metformin 1Letrozole 1Inulin 1Inositol 1Flutamide 1Clomiphene 1Chorionic Gonadotropin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anovulation × Metformin × Clear all
NCT00151411 2018-03-21

Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)

Milton S. Hershey Medical Center

Phase 2 Completed
114 enrolled 10 charts

Anovulation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡